Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Theodore Moore, M.D.
Theodore Moore, M.D.

Specialty:

Pediatric Hematology/Oncology
Pediatrics

General Information:

Gender:
Male
Language(s):
English

Affiliation(s):

Professor, Department of Pediatrics, Hematology/Oncology
Member, JCCC Cancer and Stem Cell Biology Program Area

Education:

Fellowship:
Pediatric Hematology/Oncology, UCLA School of Medicine, 1992 - 1995
Residency:
Pediatrics, UCLA School of Medicine, 1990 - 1992
Internship:
Pediatrics, UCLA School of Medicine, 1989 - 1990
Medical Degree:
M.D., Oregon Health Sciences University School of Med, 1989

Certification(s):

Medical Board Certification(s):
Pediatric Hematology-Oncology, American Board of Pediatrics, 1998
Pediatrics, American Board of Pediatrics, 1992

Contact Information:

Pediatrics:
(310) 825-6185 Information and referral
(310) 206-5737 Admissions
(310) 825-0867 Outpatient appointments
Pediatric Hematology/Oncology:
(310) 825-6708 Information
(310) 825-0867 Patient appointments
(310) 825-6185 Pediatric physician relations liaison
UCLA Sarcoma Program:
(310) 825-7086 Information and referral
Email:

Scientific Interest(s):

Dr. Theodore Moore's research focuses on pediatric hematopoietic stem cell transplantation, specifically stem cell sources and infections in the immunocompromised host. He and his colleagues also are working with acute leukemias and leukemiogenesis, as well as rare pediatric tumors and new drug development.

Selected Cancer-Related Publications:

Shankar DB, Li J, Tapang P, McCall JO, Pease LJ, Dai Y, Wei RQ, Albert DH, Bouska JJ, Osterling DJ, Guo J, Marcotte PA, Johnson EF, Soni N, Hartandi K, Michaelides MR, Davidsen SK, Priceman SJ, Chang JC, Rhodes K, Shah N, Moore TB, Sakamoto KM, Glaser KB, Owen McCall J. ABT-869 a multi-targeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia. Blood. 2007.

Parcells BW, Ikeda AK, Simms-Waldrip T, Moore TB, Sakamoto KM. FLT3 in Normal Hematopoiesis and Acute Myeloid Leukemia. Stem Cells. 2006.

Shankar DB, Cheng JC, Kinjo K, Federman N, Moore TB, Gill A, Rao NP, Landaw EM, Sakamoto KM. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell. 2005; 7(4): 351-62.

Cheng JC, Moore TB, Sakamoto KM. RNA interference and human disease. Mol Genet Metab. 2003; 80(1-2): 121-8.